BROOKLYN WHITSON: Open Payments
NPI 1629741434 · ERWIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 83 payments from 17 companies in 2025. Trend: 2023 $1,524 · 2024 $2,004 · 2025 $1,837
Food & beverage: $1,837
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 13 | $267 |
| AstraZeneca Pharmaceuticals LP | 12 | $240 |
| Novartis Pharmaceuticals Corporation | 8 | $206 |
| Calliditas Therapeutics US Inc. | 6 | $184 |
| Amgen Inc. | 10 | $174 |
| AKEBIA THERAPEUTICS INC | 3 | $172 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $158 |
| Mallinckrodt Hospital Products Inc. | 4 | $109 |
| Lilly USA, LLC | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
Products named: FARXIGA, Fabhalta, TARPEYO, Vafseo, Kerendia, KRYSTEXXA, TERLIVAZ, JARDIANCE.
Industry payments across TN — which companies pay providers there.
